Logo of Dutch technology company Philips is seen at company headquarters in Amsterdam, Netherlands, January 29, 2019. REUTERS/Eva Plevier/File
Register now for FREE unlimited access to Reuters.com
AMSTERDAM, April 25 (Reuters) – Dutch health technology company Philips (PHG.AS) on Monday said first-quarter core profit dropped about a third from a year earlier to 243 million euros ($262 million), hit by an ongoing global shortage of parts and a massive recall of ventilators.
Comparable sales fell 4% to 3.9 billion euros, as the Amsterdam-based supplier of medical systems and personal health products continued to struggle with supply chain woes and had to expand its global recall of respiratory devices once again.

vCard.red is a free platform for creating a mobile-friendly digital business cards. You can easily create a vCard and generate a QR code for it, allowing others to scan and save your contact details instantly.
The platform allows you to display contact information, social media links, services, and products all in one shareable link. Optional features include appointment scheduling, WhatsApp-based storefronts, media galleries, and custom design options.
Analysts polled by the company on average had forecast adjusted core profit – earnings before interest, taxes and amortisation – of 236 million euros, and a sales to drop of almost 8%.
Register now for FREE unlimited access to Reuters.com
Philips said it still expected sales and profitability to recover in the second half of the year, provided current problems do not get worse.
“Risks related to the COVID-19 situation in China, the Russia-Ukraine war, supply chain challenges and inflationary pressures … may impact our ability to convert our strong order book to sales and achieve our margin target if conditions deteriorate further”, Chief Executive Frans van Houten said.
Growth is also being held back by the firm’s sleep and respiratory care unit, which is still working on the massive recall of ventilators launched last year amid concerns that a type of foam used in the devices could deteriorate and become toxic. read more
Philips hiked its provision for global repair or replacement of more than 5 million devices by 165 million euros in the first quarter, taking the total costs so far to almost 900 million euros.
That sum does not cover possible litigation costs, with the company facing more than a hundred class action suits. Fears of a large claims bill have lopped around 15 billion euros off Philips’ market value since June last year.
($1 = 0.9281 euros)
Register now for FREE unlimited access to Reuters.com
Reporting by Bart Meijer; Editing by Christopher Cushing and Kenneth Maxwell
Our Standards: The Thomson Reuters Trust Principles.